High-Seas Marine Microorganism Delivers an Extract That Dampens LPS-Driven Pro-Inflammatory Signaling: Galbibacter orientalis Strain ROD011
Marine Drugs · 2025
DOI: 10.3390/md23100409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Minji Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Aquatic Organisms, Inflammation, Rhodobacteraceae. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Korea Institute of Marine Science and Technology Promotion.
Abstract (Originalsprache)
An ethyl acetate extract from the deep-sea bacterium Galbibacter orientalis strain ROD011 (GOEE), collected from international waters, was investigated as a potential anti-inflammatory agent. In lipopolysaccharide (LPS)-stimulated murine macrophages, nitric oxide (NO) production fell by 72–87% at 5–20 µg/mL GOEE without detectable cytotoxicity. Cyclooxygenase-2 (COX-2 protein abundance decreased in a dose-dependent manner and was nearly absent at 20 µg/mL. In zebrafish embryos, survival was maintained up to 40 µg/mL, and LPS-induced signals were attenuated; the cell-death rate declined from 10 µg/mL onward, and at 20 µg/mL GOEE, reactive oxygen species (ROS) and NO decreased by 85% and 27%, respectively. To explain these effects, untargeted metabolomics with pathway enrichment and network mapping were performed in LPS-driven macrophages. Of the 58 KEGG pathways evaluated, 18 reached significance, notably purine and pyrimidine metabolism, vitamin B6 metabolism, and the one-carbon pool via folate. Coordinated shifts also involved amino-acid/tricarboxylic acid (TCA)-cycle linkages, glutathione and glyoxylate/dicarboxylate, and sphingolipid pathways. Network analysis identified hubs that were concomitantly reprogrammed. Collectively, GOEE achieved multi-level suppression of inflammatory outputs while preserving viability, and the metabolomic signature provides a mechanistic scaffold for its action. These findings nominate a deep-sea microbial extract as a promising anti-inflammatory lead and motivate fractionation and targeted validation of the highlighted metabolic nodes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan 48513, Republic of Korea.
- Department of Marine Life Science, School of Marine Biomedical Sciences, Jeju National University, Jeju 63243, Republic of Korea.
- Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
- Department of Food Science and Technology, Pukyong National University, Busan 48513, Republic of Korea.
- Laboratories of Marine New Drugs, Redone Technologies Co., Ltd., Jangseong-gun 57247, Republic of Korea.
ORCID-Profile: Minji Kim, You-Jin Jeon, Young-Mog Kim, Jae-Il Kim, Sohee Kim, Jihye Lee, Jimin Hyun
Förderung
- Ministry of Science and ICT
- Korea Institute of Marine Science and Technology Promotion
Zitieren
APA
Kim, M., Jeon, Y. J., Ryu, B., Kim, Y. M., Kim, J. I., Choi, M., Kim, S., Lee, J., & Hyun, J. (2025). High-Seas Marine Microorganism Delivers an Extract That Dampens LPS-Driven Pro-Inflammatory Signaling: Galbibacter orientalis Strain ROD011. Marine Drugs. https://doi.org/10.3390/md23100409
Vancouver
Kim M, Jeon YJ, Ryu B, Kim YM, Kim JI, Choi M, et al. High-Seas Marine Microorganism Delivers an Extract That Dampens LPS-Driven Pro-Inflammatory Signaling: Galbibacter orientalis Strain ROD011. Marine Drugs. 2025. doi:10.3390/md23100409
BibTeX
@article{Kim2025,
author = {Kim, Minji and Jeon, You-Jin and Ryu, Bomi and Kim, Young-Mog and Kim, Jae-Il and Choi, Minkyeong and Kim, Sohee and Lee, Jihye and Hyun, Jimin},
title = {High-Seas Marine Microorganism Delivers an Extract That Dampens LPS-Driven Pro-Inflammatory Signaling: Galbibacter orientalis Strain ROD011},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23100409}
}
EUVIMED